Researchers assessed the clinical feasibility, efficacy, and cost economics of combination therapy with arthroscopic debridement and drug treatment in ankle acute gout arthritis.
Of 25 patients with both obesity and gout who had elevated uric acid levels prior to bariatric surgery, 10 achieved therapeutic target levels of uric acid at 12 months after the surgery, according to investigators.
Researchers compared the efficacy and safety of citrate mixture and sodium bicarbonate on urine alkalization in patients with gout receiving benzbromarone.
Kidney transplant recipients with uncontrolled gout experienced sharp declines in serum uric acid when treated with pegloticase, a pegylated recombinant uricase that metabolizes uric acid to allantoin, which is readily cleared from the circulation.
